OTC Naloxone After 2023 FDA Approval: Does It Change Counseling Practice?
A worried mother buys naloxone off the shelf, no questions asked, exactly as the 2023 OTC approval intended — then walks up to the counter anyway because she has no idea how to use it.
V.R. drove straight from work to the pharmacy counter after her son's high school called that morning about a classmate's fentanyl-related death — news that reached her before she'd had any real chance to process it herself, let alone talk to her own son about it. She is fifty-two, an accountant at a small downtown firm, coaches her daughter's youth soccer team on weekends, and has no medical background of any kind; until this morning, she had never given much thought to opioids at all beyond the occasional news story that scrolled past without sticking. Her nineteen-year-old son is home from his first year of college, and while she has no specific reason to believe he uses opioids, the day's news made her want something in the house “just in case,” a phrase she repeated twice while explaining herself to the pharmacist, as if saying it again might make it sound less alarming. She had already picked a box of the newly over-the-counter 4 mg naloxone nasal spray off the shelf herself, since it no longer requires a prescription or pharmacist consultation to purchase, but approached the counter anyway, because she genuinely doesn't know how to use it, has never seen anyone administer it, and is embarrassed to admit she isn't sure what actually counts as an overdose versus someone who is simply, deeply asleep. Her husband, watching from a few feet away, admitted he wasn't sure either, which only made her more anxious to get this right before they left the store. “Does buying it over the counter mean I'm on my own for everything else, too?” she asked, and waited for the answer.
Legal to buy without a word said doesn't mean nothing needs saying
I want to walk her through it fully, right now, even though nothing requires me to. The FDA's approval of Narcan for over-the-counter, nonprescription use in March 2023 changed the legal requirement to consult a pharmacist before purchase — it didn't change whether a first-time buyer actually knows how to recognize an opioid overdose or use the device correctly, and she just told me directly that she doesn't.
I agree with helping her specifically, since she's asking. But I want to name the broader principle carefully: the entire point of the OTC switch was to remove friction, including for purchasers who specifically don't want to be seen, questioned, or asked why they're buying it. If counseling becomes an expected default rather than a genuine offer, we risk quietly recreating the barrier this regulatory change was designed to remove.
That's a real risk in principle, but V.R. walked up to the counter and asked — nothing about helping her specifically recreates a barrier for the purchaser two aisles over who wants to grab the box and leave unbothered.
Then the structure should be genuinely opt-in rather than a binary house policy: a brief, visible sign or a single low-pressure offer at checkout ("happy to walk you through it if you'd like") that anyone can decline instantly and without follow-up questions. For V.R., who's already asking, that means a full walkthrough right now — how to recognize an overdose, how to use the device, and that calling 911 and staying with the person still matters even after a dose is given.
Agreed: V.R. received a full walkthrough on request, and the pharmacy adopted a standing, visible, genuinely optional counseling offer at checkout for OTC naloxone purchases going forward.
Not agreed: how much the pharmacy should actively track or follow up on whether purchasers who decline counseling later have questions, versus treating a declined offer as fully closed. The pharmacist wanted a take-home card with basic instructions given to every purchaser regardless of whether they accept live counseling; the harm reduction physician felt even a card, if handed over with any expectation of engagement, could undercut the anonymity some purchasers are specifically seeking.